These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14946332)

  • 1. Transitory appearance of type 2 neutralizing antibody in patients infected with type 1 poliomyelitis virus.
    SABIN AB
    J Exp Med; 1952 Jul; 96(1):99-106. PubMed ID: 14946332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies.
    MELNICK JL; KAPLAN AS
    J Exp Med; 1953 Mar; 97(3):367-400. PubMed ID: 13052807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of homotypic neutralizing antibody in human poliomyelitis three years after infection.
    WINSSER J; SABIN AB
    J Exp Med; 1952 Nov; 96(5):477-90. PubMed ID: 13000058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homotypic complement-fixing antibody in monkeys infected with type 2 poliomyelitis virus by the oral route.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):55-8. PubMed ID: 14946328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.
    GOLDBLUM N; MELNICK JL
    J Exp Med; 1952 Aug; 96(2):175-85. PubMed ID: 14955573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific complement-fixation test for infection with poliomyelitis virus.
    CASALS J; OLITSKY PK; ANSLOW RO
    J Exp Med; 1951 Aug; 94(2):123-37. PubMed ID: 14861374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, persistence, and significance of type 2, poliomyelitis complement-fixing antibody in man.
    CASALS J; OLITSKY PK; SABIN AB
    J Exp Med; 1952 Jul; 96(1):35-53. PubMed ID: 14946327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response of patients with poliomyelitis to virus recovered from their own alimentary tract.
    STEIGMAN AJ; SABIN AB
    J Exp Med; 1949 Oct; 90(4):349-72. PubMed ID: 18140667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe.
    MELNICK JL; LEDINKO N
    J Exp Med; 1950 Feb; 91(2):185-95. PubMed ID: 15409906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the homotypic specificity of poliomyelitis complement-fixing antigens by heat.
    SCHMIDT NJ; LENNETTE EH
    J Exp Med; 1956 Jul; 104(1):99-120. PubMed ID: 13332183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of neutralizing antibody for a year following vaccination of monkeys with Lansing poliomyelitis virus.
    MORGAN IM
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):305-8. PubMed ID: 14808241
    [No Abstract]   [Full Text] [Related]  

  • 12. A complement fixation test for poliomyelitis.
    SCHMIDT NJ; LENNETTE EH
    J Exp Med; 1955 Aug; 102(2):133-50. PubMed ID: 13242739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative neutralizing antibody patterns to Lansing (type 2) poliomyelitis virus in different populations.
    PAUL JR; MELNICK JL; RIORDAN JT
    Am J Hyg; 1952 Nov; 56(3):232-51. PubMed ID: 12996493
    [No Abstract]   [Full Text] [Related]  

  • 14. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.
    SVEHAG SE; MANDEL B
    J Exp Med; 1964 Jan; 119(1):1-19. PubMed ID: 14113113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some epidemiological aspects of poliomyelitis in Turkey; a serological survey for neutralizing and complement-fixing antibodies against polioviruses.
    PAYZIN S
    Bull World Health Organ; 1956; 15(1-2):339-54. PubMed ID: 13383369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poliovirus precipitins; a study by means of diffusion in agar.
    LE BOUVIER GL
    J Exp Med; 1957 Nov; 106(5):661-76. PubMed ID: 13475622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lansing poliomyelitis virus neutralizing antibody titers of different types of human serum.
    LEVINSON SO; MILZER A; WOLF AM
    Ill Med J; 1951 Oct; 100(4):238-40. PubMed ID: 14873311
    [No Abstract]   [Full Text] [Related]  

  • 18. Age incidence and seasonal development of neutralizing antibodies to lansing poliomyelitis virus.
    TURNER TB; HOLLANDER DH; BUCKLEY S; KOKKO UP; WINSOR CP
    Am J Hyg; 1950 Nov; 52(3):323-47. PubMed ID: 14789759
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiplication of certain neurotropic viruses in the rabbit eye following intraocular inoculation.
    OVERMAN JR; FRIEDEWALD WF
    J Exp Med; 1950 Jan; 91(1):39-51. PubMed ID: 15395572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. II. The development of complement-fixing antibodies.
    KRAFT LM; MELNICK JL
    J Exp Med; 1953 Mar; 97(3):401-14. PubMed ID: 13052808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.